Andrea Loewendorf is an accomplished global leader with over two decades of experience in the biopharma industry. As the Head of Immunology Canada at UCB, she spearheads UCB’s immunology strategy, translating vision into field execution and driving positive impact on patients.

With her extensive background, Andrea has successfully orchestrated global product launches, consistently prioritizing patient needs and bringing groundbreaking therapies to market. Notably, she set the global commercial strategy for a recent launch and has spent the past six years leading market access teams in the U.S. and across the globe. Her strategic vision extends beyond traditional boundaries, encompassing innovative approaches to market access, digital transformation and brand excellence.

Andrea holds an undergraduate and a master’s degree in Business Administration from Duke University in Durham, NC, both with a focus on science and healthcare. She is a passionate champion of diversity and inclusion, Women in Leadership, and currently serves on the Healthcare Businesswomen’s Association Global Board of Directors Nominating Committee, contributing to industry-wide progress.

Andrea resides in the Greater Toronto Area with her family and, outside of her professional endeavours, enjoys athletic and outdoor adventures. Her commitment to transforming patient lives aligns seamlessly with UCB’s mission and values.